CM Life Sciences II Inc.

CM Life Sciences II Inc. (Nasdaq: CMII) is a blank-check company sponsored by CM Life Sciences II LLC, an entity affiliated with Casdin Capital and Corvex Management, two investment firms with deep roots in the life sciences and healthcare sectors. The SPAC completed its initial public offering in 2021 targeting opportunities in life sciences, healthcare, and related technology businesses. In December 2023, CMII filed a DEFM14A — a definitive merger proxy — with the SEC, indicating the company had advanced to the shareholder-approval stage of a proposed business combination. Visit SpacDesk and sign up for full access to CMII's deal timeline, filing history, and comparable transaction data.